Renal cell carcinoma drug and cell therapy: today and tomorrowThe paper also looks at clinically applicable
targeted immune drugs and the principle
Promising New Tools for Targeting p53 Mutant Cancers: Humoral and Cell-Based Immunotherapies antigens as molecular
targets in immunotherapy, including the application of T
cell receptor mimic (TCRm
Cell targets of antitumor ribonucleasesSeveral ribonucleases (RNases) are known to exert a toxic effect on tumor
cells, but the mechanism
Artificial Glycoproteins as a Scaffold for Targeted Drug Therapy,” the glycocalyx is a glycan-enriched cellular coating that plays a crucial role in mediating
cell-to-cell